Results of the BRIGHT study: The randomized controlled trial compared the efficacy and safety of Toujeo versus insulin degludec at 24 weeks
1 factor holding back GLP-1 adoption, stigma might have been the No
Your provider determines whether peptide therapy may be appropriate
Edinoff AN, Silverblatt NS, Vervaeke HE, et al
If you find the 45 unit mark uncomfortably small to read, the honest options are (a) use a finer-gradation syringe, or (b) follow a protocol built around the 50 mg vial, whose larger draw is more forgiving not to freehand a bigger volume from the 10 mg vial, which would silently overdose relative to the documented figure
The Tablets: Their Role in B12 Management On the other hand, B12 tablets are a convenient and non-invasive option